Soleno Therapeutics, Inc.SLNONASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+137.7%
5Y CAGR+82.3%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+137.7%/yr
vs +10.7%/yr prior
5Y CAGR
+82.3%/yr
Recent acceleration
Acceleration
+127.0pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
20.1x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$132.13M+24.8%
2024$105.86M+685.3%
2023$13.48M+36.9%
2022$9.84M-8.9%
2021$10.81M+64.6%
2020$6.56M+41.7%
2019$4.63M-29.3%
2018$6.56M-0.8%
2017$6.61M-21.0%
2016$8.37M-